Eli Lilly (NYSE:LLY) Surges 5% Following Breakthrough BRAVE-AA-PEDS Study Results
Recent developments at Eli Lilly (NYSE:LLY) have highlighted significant strides in both product innovation and operational ...
Fierce Pharma13h
Senators expand probe of Pfizer, Lilly DTC platforms to include telehealth provider partners
In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...
RiverBender.com2d
Durbin, Warren, Welch, Sanders Demand Answers From Telehealth Companies Regarding Their Financial Relationship With Pfizer, Eli Lilly Amid Concerns
WASHINGTON, D.C. U.S. Senate Democratic Whip Dick Durbin (D-IL) sent letters to five telehealth companies that have held ...
Health on MSN8d
Zepbound Is Now Available in Additional Doses at Lower Costs
Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...
Investor's Business Daily on MSN4d
Novo Nordisk Dives 9%. Why Eli Lilly Now Has The Upper Hand.
Novo Nordisk stock tumbled Monday after its experimental weight-loss drug failed to top its rival from Eli Lilly in a Phase 3 study.
STAT2d
Telehealth platforms in senators’ crosshairs over relationship with Eli Lilly, Pfizer
Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.
Eli Lilly plans to launch weight-loss drug in emerging markets this year
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
Modern Healthcare8d
Teladoc, LifeMD partner with Eli Lilly on GLP-1s
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
Forbes12d
LLY Stock: Should You Buy After A 20% Rise?
Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...